17 results
10-Q
2021 Q2
CADL
Candel Therapeutics Inc
8 Sep 21
Quarterly report
8:37am
three to five years.
There has been increasing legislative and enforcement interest in the U.S. with respect to specialty drug pricing practices … , bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer
10-K
2021 FY
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. presidential executive orders … , congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce
S-1
cu9ennlq3bd42k8 izf
25 Jun 21
IPO registration
5:28pm
DRS/A
wf24p jf00tpingk
31 Mar 21
Draft registration statement (amended)
12:00am
S-1/A
qr16jg1wro9
16 Jul 21
IPO registration (amended)
6:07am
424B4
7pxq7jps1i02xzz3mh
28 Jul 21
Prospectus supplement with pricing info
4:02pm
- Prev
- 1
- Next